Enterocolitis, Pseudomembranous: Clinical Trials

9 trials for Enterocolitis, Pseudomembranous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 recruiting, 1 terminated. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 7, Recruiting 1, Terminated 1

Follow Enterocolitis, Pseudomembranous: new trials by email Literature Review of Enterocolitis, Pseudomembranous trials Research Report on Enterocolitis, Pseudomembranous

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Fidaxomicin, Vancomycin capsule - Clostridia Difficile Colitis
Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre5002026-04-242026-09-23
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
RBX2660 - Clostridium Difficile Infection Recurrence
Phase 3CompletedFerring Pharmaceuticals412023-04-212026-04-24
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
RBX2660 - Clostridium Difficile Infection, Infection
Phase 3CompletedRebiotix Inc.7932019-07-302024-08-07
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
RBX2660, Placebo, Open label RBX2660 (only for confirmed CDI recurrence) - Clostridium Difficile Infection (CDI)
Phase 3CompletedRebiotix Inc.3202017-07-312024-07-10
A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea
GT267-004 (tolevamer potassium sodium) - Enterocolitis, Pseudomembranous, Diarrhea
Phase 3TerminatedGenzyme, a Sanofi Company652007-04-012015-03-19
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
Tolevamer potassium-sodium (GT267-004) - Clostridium Enterocolitis, Diarrhea
Phase 3CompletedGenzyme, a Sanofi Company5202005-04-012014-03-19
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
tolevamer potassium-sodium (GT267-004) - Clostridium Enterocolitis, Pseudomembranous Colitis
Phase 3CompletedGenzyme, a Sanofi Company5202005-03-012015-03-05
Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
Metronidazole and Rifampin - Clostridium Enterocolitis, Antibiotic-Associated Diarrhea
Phase 3CompletedMcMaster University1002004-02-012018-08-15
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Nitazoxanide - Clostridium Enterocolitis, Pseudomembranous Colitis
Phase 3CompletedDaniel M. Musher MD222004-01-012017-12-15

Narrower conditions

Diarrhea (5)  ·  Clostridium Infections (2)  ·  Communicable Diseases (1)  ·  Dysentery (1)  ·  Infections (1)

Broader conditions

Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Digestive System Diseases (9)  ·  Enterocolitis (9)  ·  Gastroenteritis (9)  ·  Gastrointestinal Diseases (9)  ·  Gram-Positive Bacterial Infections (9)  ·  Intestinal Diseases (9)  ·  Infections (8)  ·  Clostridium Infections (7)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Signs and Symptoms, Digestive (5)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)

Interventions

Fidaxomicin (1)  ·  Metronidazole (1)  ·  Rifampin (1)  ·  Saline Solution (1)  ·  Single Person (1)  ·  Vancomycin (1)  ·  nitazoxanide (1)

Sponsors

Genzyme, a Sanofi Company (3)  ·  Rebiotix Inc. (2)  ·  Daniel M. Musher MD (1)  ·  Ferring Pharmaceuticals (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  McMaster University (1)

Countries

United States (6)  ·  Canada (5)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Norway (1)  ·  Portugal (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Teena Chopra, M.D., M.P.H. (2)  ·  Christine H Lee, MD (1)  ·  Daniel M Musher, M.D. (1)  ·  Emily McDonald, MD MSc (1)  ·  Todd Lee, MSc MPH (1)

Results publications

PMID 42286373, PMID 24799326, PMID 41245385, PMID 36287379, PMID 37564743, PMID 38236515, PMID 39172632, PMID 39180326, PMID 40177588, PMID 40321366, PMID 40552763, PMID 40672762, PMID 40784972, PMID 41115624, PMID 41230019, PMID 41647268, PMID 41653256, PMID 42840322